KBI Biopharma, a JSR Life Sciences company, is a global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. KBI works closely to personalize and rapidly accelerate drug development programs. Built upon a foundation of world-class analytics capabilities, extensive scientific and technical expertise, KBI delivers robust process development, clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, KBI helps partners advance drug candidates into the clinic and beyond. KBI serves its global partners through multiple locations in Europe and USA.